PA
ADT icon

PharVision Advisers’s ADT ADT Stock Holding History

PharVision Advisers’s Portfolio ADT Stock Details ADT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-19,273
Closed -$163K – 658
2025
Q2 		$163K Buy
+19,273
New +$158K 0.23% 222
2025
Q1 		– Sell
-48,807
Closed -$337K – 268
2024
Q4 		$337K Buy
+48,807
New +$355K 0.29% 119

Other funds holding ADT

State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

PharVision Advisers's ADT Position: Q3 2025 in Review

PharVision Advisers sold out of ADT (ADT) in Q3 2025, closing a stake of 19,273 shares — an estimated $163K sold.

PharVision Advisers first reported a position in ADT in Q4 2024 and held it in 2 quarters. The position peaked at $337K in Q4 2024. 461 funds tracked by Wall St. Rank hold ADT as of Q3 2025.

  • PharVision Advisers reported no remaining ADT position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 19,273 ADT shares in Q3 2025, an estimated $163K.
  • PharVision Advisers first reported a position in ADT in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's ADT position peaked at $337K in Q4 2024.
  • 461 funds tracked by Wall St. Rank held ADT as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.